COVID-19

ValerieMarie Moore filed a notice of appealing a June 3 ruling to the 2nd District Court of Appeal. The case is one of numerous similar lawsuits filed in Florida and other states seeking refunds for students.

The chair of the WHO's investigative group said that most scientific data supports the hypothesis that the new coronavirus jumped to humans from animals.

The biggest questions are whether people can still choose to receive the vaccine even if it's not recommended for them and whether insurance will cover the cost.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older. What's the change?

The shot has been available under emergency use since 2022 and is the nation’s only traditional protein-based option for COVID-19. Now experts are questioning whether other vaccines will be caught in the turmoil.

Lori Freeman, CEO of the National Association of County & City Health Officials, said much of the funding was set to end soon anyway.

Dr. Jay Bhattacharya, nominated to lead the National Institutes of Health, opposed most mandates. Without an honest public debate about what worked, experts say, we’re even less prepared for the next pandemic.

A Washington Post health columnist outlines priorities shaping public health policy. Then, an insurance expert untangles the complicated web of health insurance.

The CIA assessment, completed under the Biden administration, points the finger at China even while acknowledging “low confidence” in the conclusion. It was ordered released by new CIA chief John Ratcliffe.

To deliver on pledges from the Trump administration to make America healthy again, policymakers will need to close gaps in longevity among racial and ethnic groups.